(Q73014659)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Containment of heart failure hospitalizations and cost by angiotensin-converting enzyme inhibitor dosage optimization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

A B Luzier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Forrest

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S G Feuerstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J J Schentag

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J L Izzo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

519-523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Evidence of inadequate investigation and treatment of patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Patterns of prescribing ACE inhibitors after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901005-5

10.1016/S0002-9149(00)01005-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009269%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference